148 related articles for article (PubMed ID: 37916054)
1. Retained Products of Conception (RPOC): Diagnosis, Complication & Management.
Chawla S; Sharma R
J Obstet Gynaecol India; 2023 Oct; 73(5):374-380. PubMed ID: 37916054
[TBL] [Abstract][Full Text] [Related]
2. Hysteroscopy and Retained Products of Conception: An Update.
Foreste V; Gallo A; Manzi A; Riccardi C; Carugno J; Sardo ADS
Gynecol Minim Invasive Ther; 2021; 10(4):203-209. PubMed ID: 34909376
[TBL] [Abstract][Full Text] [Related]
3. Hysteroscopic Removal of Retained Products of Conception Implanted Over a Focal Area of Adenomyosis: A Case Report.
Alonso L; Nieto L; Carugno J
J Minim Invasive Gynecol; 2018; 25(3):382-383. PubMed ID: 28939480
[TBL] [Abstract][Full Text] [Related]
4. Enhanced myometrial vascularity: case presentation and review.
Woo J; Kahn B
Fertil Steril; 2021 Sep; 116(3):912-914. PubMed ID: 34217488
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine adhesions after hysteroscopic treatment for retained products of conception: what are the risk factors?
Barel O; Krakov A; Pansky M; Vaknin Z; Halperin R; Smorgick N
Fertil Steril; 2015 Mar; 103(3):775-9. PubMed ID: 25527235
[TBL] [Abstract][Full Text] [Related]
6. Postpartum retained products of conception: Is it possible to avoid postpartum curettage?
Nir A; Mor M; Yekutiel M; Eisenberg N; Smorgick N
Int J Gynaecol Obstet; 2022 Feb; 156(2):231-235. PubMed ID: 33811338
[TBL] [Abstract][Full Text] [Related]
7. Office hysteroscopy in removing retained products of conception - a highly successful approach with minimal complications.
Jakopič Maček K; Blaganje M; Kenda Šuster N; Drusany Starič K; Kobal B
J Obstet Gynaecol; 2020 Nov; 40(8):1122-1126. PubMed ID: 31793362
[TBL] [Abstract][Full Text] [Related]
8. Hysteroscopic management of retained products of conception: A systematic review.
Taylor C; Ellett L; Hiscock R; Mooney S
Aust N Z J Obstet Gynaecol; 2022 Feb; 62(1):22-32. PubMed ID: 34751942
[TBL] [Abstract][Full Text] [Related]
9. Hysteroscopic management of retained products of conception: meta-analysis and literature review.
Smorgick N; Barel O; Fuchs N; Ben-Ami I; Pansky M; Vaknin Z
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():19-22. PubMed ID: 24332096
[TBL] [Abstract][Full Text] [Related]
10. Two-step hysteroscopy for management of morbidly adherent retained products of conception.
Smorgick N; Rabinovitch I; Levinsohn-Tavor O; Maymon R; Vaknin Z; Pansky M
Arch Gynecol Obstet; 2019 Sep; 300(3):669-674. PubMed ID: 31321494
[TBL] [Abstract][Full Text] [Related]
11. Hysteroscopic resection for management of early pregnancy loss: a case report and literature review.
Young S; Miller CE
F S Rep; 2022 Jun; 3(2):163-167. PubMed ID: 35789723
[TBL] [Abstract][Full Text] [Related]
12. Hysteroscopic removal of retained products of conception following first trimester medical abortion.
Smorgick N; Levinsohn-Tavor O; Ben-Ami I; Maymon R; Pansky M; Vaknin Z
Gynecol Minim Invasive Ther; 2017; 6(4):183-185. PubMed ID: 30254910
[TBL] [Abstract][Full Text] [Related]
13. Management of Acquired Uterine Arteriovenous Malformations Associated with Retained Products of Conception.
Gao F; Ma X; Xu Y; Fu L; Guo X
J Vasc Interv Radiol; 2022 May; 33(5):547-553. PubMed ID: 35093540
[TBL] [Abstract][Full Text] [Related]
14. A comparison of reproductive outcomes following hysteroscopic management versus dilatation and curettage of retained products of conception.
Ben-Ami I; Melcer Y; Smorgick N; Schneider D; Pansky M; Halperin R
Int J Gynaecol Obstet; 2014 Oct; 127(1):86-9. PubMed ID: 24997472
[TBL] [Abstract][Full Text] [Related]
15. Operative hysteroscopy in the minimally invasive management of interstitial pregnancy and interstitially retained products of conception: A case report and systematic literature review.
D'hoore E; D'hoore L; Van den Berghe S; Roets E; van Wessel S; Hamerlynck T
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():54-59. PubMed ID: 34428687
[TBL] [Abstract][Full Text] [Related]
16. A Case of Placenta Accreta Infection Managed by Hysterectomy After Treatment for Retained Products of Conception With Uterine Artery Embolization and Hysteroscopy.
Fukuoka H; Sato H; Okabe M; Togashi K; Oyama N
Cureus; 2023 Apr; 15(4):e37854. PubMed ID: 37223160
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonographic technique to differentiate enhanced myometrial vascularity/arteriovenous malformation from retained products of conception.
Thakur M; Strug MR; De Paredes JG; Rambhatla A; Munoz MIC
J Ultrasound; 2022 Jun; 25(2):379-386. PubMed ID: 33651329
[TBL] [Abstract][Full Text] [Related]
18. Utility of Office Hysteroscopy in Diagnosing Retained Products of Conception Following Early Pregnancy Loss After In Vitro Fertilization.
George JS; Naert MN; Lanes A; Yin S; Bharadwa S; Ginsburg ES; Srouji SS
Obstet Gynecol; 2023 Nov; 142(5):1019-1027. PubMed ID: 37769303
[TBL] [Abstract][Full Text] [Related]
19. Outcome of using vaginal misoprostol for treatment of retained products of conception after first trimester miscarriage: a retrospective cohort study.
Stewart KT; Lee JS; Pan K; Albert AY; Fisher S
Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):474-479. PubMed ID: 32869658
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of uterine artery embolization with gelatin sponge for retained products of conception with bleeding and future pregnancy outcomes.
Kimura Y; Osuga K; Nagai K; Hongyo H; Tanaka K; Ono Y; Higashihara H; Matsuzaki S; Endo M; Kimura T; Tomiyama N
CVIR Endovasc; 2020 Feb; 3(1):13. PubMed ID: 32052234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
